Schneider Jennifer — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Schneider Jennifer has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Jennifer Schneider serves as a non-executive director on the board of Vertex Pharmaceuticals Incorporated (Massachusetts) as of the latest SEC filing dated May 5, 2026. Vertex is a leading biotechnology company focused on developing therapies for serious diseases. The SEC filing context confirms her role as a director; other professional background details are not provided in that filing, so further sources would be needed to outline prior positions or career highlights.
Role
Director
Notability
40/100
Board memberships
Vertex Pharmaceuticals Incorporated
Awards & honors
Board member at Vertex Pharmaceuticals (as of 2026)
Jennifer Schneider serves as a non-executive director on the board of Vertex Pharmaceuticals Incorporated (Massachusetts) as of the latest SEC filing dated May 5, 2026. Vertex is a leading biotechnology company focused on developing therapies for serious diseases. The SEC filing context confirms her role as a director; other professional background details are not provided in t…
How many SEC Form 4 filings has Schneider Jennifer submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Schneider Jennifer's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
